Good afternoon :)
Place Order
Add to Watchlist

Remus Pharmaceuticals Ltd

REMUS

Remus Pharmaceuticals Ltd

REMUS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,016 cr, stock is ranked 1,293
High RiskStock is 5.88x as volatile as Nifty
6,899.3512.93% (+789.85)
6,899.3512.93% (+789.85)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,016 cr, stock is ranked 1,293
High RiskStock is 5.88x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,016 cr, stock is ranked 1,293
High RiskStock is 5.88x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
53.10
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.915.950.56%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Remus Pharmaceuticals Limited is an India-based company that is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. It also deals in active pharmaceutical ingredients (API). The Company also provides technical consulting services to various distributors for the preparation of reports on the dossiers of the products. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablet. The Company’s business verticals include the sale of finished formulations, the sale of APIs, and technical consulting. Its product portfolio comprises a range of therapeutic drugs, namely ACE inhibitors, analgesics, anti-erectile dysfunction, anti-fibrinolytics, anti-histamines, beta blockers, carcinoid tumors, chronic obstructive pulmonary disease, and contrast reagents, among others.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023TTM
Total Revenue12.7719.2325.4446.61
Raw Materialssubtract7.4412.2112.7120.14
Power & Fuel Costsubtract0.010.000.000.00
Employee Costsubtract2.862.953.425.47
Selling & Administrative Expensessubtract1.370.002.703.26
Operating & Other expensessubtract-0.152.461.755.61
Depreciation/Amortizationsubtract0.110.180.150.48
Interest & Other Itemssubtract0.040.030.090.23
Taxes & Other Itemssubtract0.290.351.182.91
EPS8.0010.5034.4081.63
DPS0.000.000.00
Payout ratio0.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Remus Pharmaceuticals Ltd119.4253.10
Sun Pharmaceutical Industries Ltd45.896.560.71%
Cipla Ltd43.135.100.57%
Dr Reddy's Laboratories Ltd22.754.400.65%

Price Comparison

Compare REMUS with any stock or ETF
Compare REMUS with any stock or ETF
REMUS
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 23.21%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.61%0.00%0.71%2.38%27.30%

Mar 2023

May 2023

Sep 2023

Shareholding History

MarMaySep0.00%2.55%2.38%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

REMUS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateOct 27, 2023

Interim
Interim | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Oct 27, 2023

Cash Dividend

Ex DateEx DateSep 15, 2023

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 15, 2023

News & Opinions

Hmm, looks like data is unavailable here. Please come back after some time.